Evidence map›Paper›PMID 25815777›Full record

ArticleMolecular medicine reports2015

cDNA microarray analysis of the effect of cantharidin on DNA damage, cell cycle and apoptosis-associated gene expression in NCI-H460 human lung cancer cells in vitro.

Te-Chun Hsia, Chien-Chih Yu, Shu-Chun Hsu, Nou-Ying Tang, Hsu-Feng Lu, Chun-Shu Yu, Shin-Hwar Wu, Jaung-Geng Lin, Jing-Gung Chung

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. GL4SDA: Predicting snoRNA-disease associations using GNNs and LLM embeddings.Computational and structural biotechnology journal · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2017
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Te-Chun HsiaGraduate Institute of Chinese Medicine, China Medical University, Taichung 40402, Taiwan, R.O.C.
Chien-Chih YuSchool of Pharmacy, China Medical University, Taichung 40402, Taiwan, R.O.C.
Shu-Chun HsuDepartment of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan, R.O.C.
Nou-Ying TangGraduate Institute of Chinese Medicine, China Medical University, Taichung 40402, Taiwan, R.O.C.
Hsu-Feng LuDepartment of Clinical Pathology, Cheng Hsin General Hospital, Taipei 11220, Taiwan, R.O.C.
Chun-Shu YuSchool of Pharmacy, China Medical University, Taichung 40402, Taiwan, R.O.C.
Shin-Hwar WuDivision of Critical Care Medicine, Department of Medicine, Changhua Christian Hospital, Changhua 50006, Taiwan, R.O.C.
Jaung-Geng LinGraduate Institute of Chinese Medicine, China Medical University, Taichung 40402, Taiwan, R.O.C.
Jing-Gung ChungDepartment of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan, R.O.C.
China Medical University · TWChanghua Christian Hospital · TWCheng Hsin General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cantharidin (CTD) induces cytotoxic effects in different types of human cancer cell; however, to date, there have been no studies on the effects of CTD on gene expression in human lung cancer cells and the potential associated signaling pathways. Therefore, the present study aimed to investigate how CTD affects the expression of key genes and functional pathways of human H460 lung cancer cells using complementary DNA microarray analysis. Human H460 lung cancer cells were cultured for 24 h in the presence or absence of 10 µM CTD; gene expression was then examined using microarray analysis. The results indicated that 8 genes were upregulated > 4-fold, 29 genes were upregulated >3-4-fold and 156 genes were upregulated >2-3-fold. In addition, 1 gene was downregulated >4 fold, 14 genes were downregulated >3-4-fold and 150 genes were downregulated >2-3 fold in H460 cells following exposure to CTD. It was found that CTD affected DNA damage genes, including DNIT3 and GADD45A, which were upregulated 2.26- and 2.60-fold, respectively, as well as DdiT4, which was downregulated 3.14-fold. In addition, the expression of genes associated with the cell cycle progression were altered, including CCND2, CDKL3 and RASA4, which were upregulated 2.72-, 2.19- and 2.72-fold, respectively; however, CDC42EP3 was downregulated 2.16-fold. Furthermore, apoptosis-associated genes were differentially expressed, including CARD6, which was upregulated 3.54-fold. In conclusion, the present study demonstrated that CTD affected the expression of genes associated with DNA damage, cell cycle progression and apoptotic cell death in human lung cancer H460 cells.

Indexed as

Gene Expression Regulation, NeoplasticAntineoplastic AgentsApoptosisCantharidinCarcinoma, Non-Small-Cell LungCell CycleCell Cycle ProteinsCell Line, TumorCyclin D2DNA DamageEnzyme InhibitorsGADD45 ProteinsGene Expression ProfilingGene OntologyHumansMicroarray AnalysisAntineoplastic AgentsCantharidinCCND2 protein, humanCDKL3 protein, humanCell Cycle ProteinsCyclin D2DDIT4 protein, humanEnzyme InhibitorsGADD45A protein, humanGADD45 ProteinsNuclear ProteinsProtein Serine-Threonine KinasesRASA4 protein, humanras GTPase-Activating ProteinsTranscription Factors

Identifiers

PMID25815777
PMCPMC4438957
OpenAlexW2078763565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.